Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — H1 FY2026 Earnings Presentation
30 slides from Gpt Healthcare's earnings presentation, Nov 8, 2025
Slide 1: Submission of Investor Presentation to Stock Exchanges
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2025-26 November 8, 2025 The Department of Corporate Services Natio
Slide 2: GPT Healthcare Limited Investor Presentation – H1 FY26
GPT Healthcare Limited Investor Presentation – H1 FY26 N S E : G P T H E A LT H | B S E : 5 4 4 1 3 1
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Karmyogi and Samaj Sevak Late Shri Dwarika Prasad Tantia
"कमर्�ेवािधकार�े मा फले षु कदाचन। मा कमर्फलहे तुभूर्मार् ते संगोऽ�कमर्िण॥ Karmyogi and Samaj Sevak Late Shri Dwarika Prasad Tantia May 27, 1954 – August 17, 2025 He was our North Star, a true karmyogi whose life was a testament to purpose and perseverance. He showed us that greatness lies in humilit
Slide 5: Table of Content
Table of Content 1 2 3 4 H1 FY26 Company Business Annual Performance Overview Highlights Financials 4
Slide 6: Q2 & H1 FY26 Performance
mB ae ba Q2 & H1 FY26 Performance =" ——— . : ‘ N
Slide 7: GPT Healthcare – Key regional corporate healthcare companies in Eastern India
GPT Healthcare – Key regional corporate healthcare companies in Eastern India Strategically located in Densely Populated Micro Markets of Kolkata, Howrah, Agartala and Raipur Established Right-Sized, Full-Service Hospitals according to each sub-region, aids High Return on C apital The company
Slide 8: Financial Highlights – H1 FY26
Financial Highlights – H1 FY26 Net Profit: Rs 18.30 Cr 43% Tax: Rs 7.89 Cr 18% 19% EBITDA : Depreciation: Rs 13.03 Cr 30% Rs 43.01 Cr Finance Costs Rs 3.8 C r 9% Total Income : Rs 228.92 C r Medicines and Consumables: 23% 100 % Rs 42.86 C r __% Employee Benefit Costs : Rs 40.72 C r 22% Total Expense
Slide 9: Road Ahead
Road Ahead Margins Maintain long term Return on Equity and Return on Capital Employed close to 25% Size Return Ratios Target to become a 1,000 Maintain long term Return on Equity and bed facility in the next Return on Capital 2 years with a focus on Employed close to 25% Tier I and Tier II cities in
Slide 10: Hospital wise Performance – H1FY26
Hospital wise Performance – H1FY26 Bed Capacity Revenue Bed Occupancy Rate ARPOB Year of Commissioning (No. of Beds) (Rs in Crore) (%) (Rs Per day) 61.56% Salt Lake Hospital 2000 85 39.3 41,062 52.72% Agartala Hospital 2011 205 69.2 34,993 64.15% Dum Dum Hospital 2013 155 76.5 42,033 41.62% Howrah H
Slide 11: Profit & Loss Highlights – Q2 & H1 FY26
Profit & Loss Highlights – Q2 & H1 FY26 Particulars (Rs Cr) Q2FY26 Q2FY25 YoY Q1 FY26 QoQ H1FY26 H1FY25 YoY Revenue from operations 118.9 105.7 12.5% 107.1 11.0% 226.0 203.5 11.1% Other Income 1.3 2.8 -52.3% 1.6 -14.4% 2.9 5.0 -42.4% Total Income 120.2 108.5 10.9% 108.7 10.7% 228.9 208.5 9.8% Cost o
Slide 12: Key Growth Initiatives
Key Growth Initiatives Continued Investment in Infrastructure New Hospital Installed cutting-edge robotic surgical Existing Hospitals technology in Salt Lake and Howrah Hospital Setting up hospitals on Asset-light basis with 700+ robotic surgeries successfully where investment in land and buildi
Slide 13: Company Overview
Company Overview
Slide 14: Salt Lake Hospital (Year 2000)
Salt Lake Hospital (Year 2000) Total 85 Beds, a high end Surgical centre with Robot enabled Operating theatre The Department of Minimal Access Surgery is accredited by National Board of Examinations for training of post-graduate surgeons under the Fellowship of National Board in Minimal Access Surge
Slide 15: Agartala Hospital (Year 2011)
Agartala Hospital (Year 2011) Total 205 Beds, including 66 Beds across ICUs along with 8 OTs & 1 catheterization laboratory The only NABH accredited hospital in Agartala and one among 11 valid accredited hospitals in North-East India as of October 2023. Also accredited by NABL Received the ‘Excellen
Slide 16: Dum Dum Hospital (Year 2013)
Dum Dum Hospital (Year 2013) Total 155 Beds, including 53 Beds across ICUs and HDUs along with 4 OTs & 1 catheterization laboratory NABH accredited and NABL accredited for complying with ISO 15189:2012 standards in the field of medical testing Recognized by the CII for Excellence in Nursing for thei
Slide 17: Howrah Hospital (Year 2019)
Howrah Hospital (Year 2019) Total 116 Beds, including 43 Beds across ICUs and HDUs along with 3 OTs & 1 catheterization laboratory Near Howrah station, the site holds strong potential with no hospital within 5 km Recognized by the CII for Excellence in Nursing for their efforts, commitment and contr
Slide 18: New ILS Raipur Hospital – (May 2025)
New ILS Raipur Hospital – (May 2025) Quaternary Care, 158 beds including ICUs & HDUs, 5 OTs, and Oncology facilities. At Pachpedi Naka, Raipur, the facility will serve patients across Raipur, Bilaspur, Durg, and Bhilai. Equipped with 3 Tesla MRI, Cardiac Cath Lab and Dual Source CT Scan for precise
Slide 19: Business Highlights
Business Highlights
Slide 20: Focused on High Return on Capital – Factors that lead to it
Focused on High Return on Capital – Factors that lead to it Strategic Location Disciplined Approach Brand Strength Right Sized, towards C osts demonstrated through of the Hospitals Full Service Payor Mix Being in populous neighbourhoods Operating multispecialty, mid sized Strategic measures towards
Slide 21: Professional and experienced leadership – Board of Directors
Professional and experienced leadership – Board of Directors Dr. Om Tantia Shree Gopal Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Managing Director Vice Chairman Executive Director Non - Executive Director Non - Executive Director C C M M M • Founding member of ILS Hospital
Slide 22: Annual Performance
Annual Performance
Slide 23: Key Financial Metrics
Key Financial Metrics Revenue from Operations (Rs Cr) EBITDA & EBIDTA Margin PAT & PAT Margin 21.8% 23.0% 22.1% 22.3% 11.8% 12.0% 11.4% 400 407 18.8% 361 50 8.0% 204 226 10.6% 39 48 43 25 46 18 80 93 92 FY23 FY24 FY25 H1FY25 H1FY26 FY23 FY24 FY25 H1FY25 H1FY26 FY23 FY24 FY25 H1FY25 H1FY26 EBITDA (Rs
Slide 24: Key Operational Metrics
Key Operational Metrics No. of Beds & Occupancy Rate (%) Average Length of Stay (ALOS) Average Revenue per Occupied Bed (ARPOB) (in Rs per day) 58.9% 58.9% 53.76% 44.70% 53.1% 38,376 37,180 36,676 719 32,947 29,671 561 561 561 561 4.22 3.95 3.54 3.51 3.49 FY23 FY24 FY25 H1FY25 H1FY26 FY23 FY24 FY25
Slide 25: Diverse Revenue Mix Across Top 10 Specialties
Diverse Revenue Mix Across Top 10 Specialties Internal Medicine & Diabetology Nephrology General Surgery Critical Care Paediactics Gastroenterology Gynaecology and obstetrics Interventional cardiology Orthopaedics and Joint Replacement Neurosciences Others 10% 12% 12% 3% 19% 3% 19% 19% 5% 6% 7% 8% 4
Slide 26: Balance Sheet
Balance Sheet Assets (Rs Cr) Mar-25 Sep-24 Sep-25 Liabilities (Rs Cr) Mar-25 Sep-24 Sep-25 PPE 202.6 198.7 261.6 Share Capital 82.1 82.1 82.0 Other Equity 165.8 148.9 171.8 Other Non-Current Asset 46.3 55.4 114.5 Total Equity 247.9 231 253.8 Investments 56.5 22.9 - Borrowings 5.5 2.3 10.2 Non-Curren
Slide 27: Profit & Loss
Profit & Loss Particulars (Rs Cr) FY25 H1FY25 H1FY26 Revenue from operations 407.1 203.5 226.0 Other Income 8.5 5.0 2.9 Total Income 415.6 208.5 228.9 Cost of materials consumed 78.8 38.7 42.9 Employee benefits expense 73 36.5 40.7 Other expenses 171.9 87.0 102.3 EBITDA 91.9 46.4 43.0 EBITDA Margin
Slide 28: Cash Flow Statement
Cash Flow Statement Particulars (in Cr) Mar-25 Sep-24 Sep-25 Cash Flow from Operating Activities Profit before Tax 35.4 26.2 69.3 Adjustment from Non-Operating Items Operating Profit before Working Capital 88.1 44.1 40.7 (Increase)/decrease in Inventories -0.7 -0.9 -3.4 (Increase)/decrease in Trade
Slide 29: Stock Information
Stock Information Share Price Movement Shareholding Pattern (as on October 31, 2025) 200 Interim Dividend of Re.1/- 180 Public Promoters 24.7% 65.6% 160 DII 140 6.5% FII 120 3.2% Price in Rs 100 80 Promoters FII DII Public 60 Script Related Information (as on 31-October-2025) 40 BSE/NSE Code 544131
Slide 30: Thank You
Thank ou GPT Healthcare Limited CIN No.: L70101WB1989PLC047402 ir@gptgroup.co.in +91-8981441481 For more details : www.ilshospitals.com